Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phospholipid bilayer lipid headgroups are the hydrophilic moieties of phospholipids that constitute the surface of biological membranes (Alberts et al., Molecular Biology of the Cell, 2002). These headgroups, which include choline, ethanolamine, serine, and glycerol, determine the surface charge and chemical environment of the cell, influencing the recruitment of peripheral membrane proteins and the activity of integral membrane proteins (Yeagle, The Membranes of Cells, 2016). In a therapeutic context, they serve as primary targets for membrane-active agents, particularly antimicrobial peptides and lipopeptides like polymyxins, which exploit the high density of negatively charged headgroups in bacterial membranes compared to host cells (Zavascki et al., 2007, PubMed: 17303205). Beyond infectious diseases, the spatial distribution and composition of these headgroups are altered in conditions such as cancer and apoptosis, where the externalization of phosphatidylserine serves as a signal for phagocytosis (Birge et al., 2016, PubMed: 27140554). Consequently, targeting or monitoring these headgroups is a vital strategy in drug development for anti-infectives and diagnostic imaging. Understanding the biophysical interactions at the headgroup level is essential for minimizing off-target effects like hemolysis or nephotoxicity associated with membrane-disrupting drugs (Vaara, 1992, PubMed: 1329317).
Drugs typically interact with phospholipid headgroups through electrostatic and hydrophobic interactions, leading to membrane permeabilization, pore formation, or disruption of membrane-associated signaling pathways (Pogliano et al., 2012, PubMed: 22585460).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phospholipid bilayer lipid headgroups.